Sopharma issued the following announcement on March 6.
Sopharma AD notifies that for February 2019 the Company recorded a decrease of sales revenues of 14% compared to the same month of 2018, including 38% decrease of domestic sales and an increase of 1% of export sales.
During the first two months of 2019 the revenues from sales of production increased by 1% compared to the same period of 2018, including 15% decrease in domestic sales and 13% increase of export sales.
Original source can be found here.
